FDA Establishes Class II Classification for TENS Devices Intended to Reduce Fibromyalgia Symptoms

FDA has established a new Class II classification with special controls for transcutaneous electrical nerve stimulators (TENS) intended to treat fibromyalgia symptoms, creating a new regulatory pathway for manufacturers.